Trial NCT05943990

View at ClinicalTrials.gov 
Org. Study IDs: 209012 Substudy 2
Secondary IDs: 2019-004446-14

Last trial update was posted on 2024-03-18

MeSH Interventions

Cyclophosphamide Fludarabine

MeSH Conditions

Liposarcoma Liposarcoma, Myxoid Sarcoma Sarcoma, Synovial

Other Conditions

Neoplasms

Stopping Reasons

The study was terminated due to a change in GSK's R&D priorities.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID